Navigation Links
Down syndrome simulated in animal model after successful chromosome transplantation

The field of genetics has been undergoing a revolution with increasing importance being given to genetic mechanisms underlying common disorders and a huge amount of resources allocated to research in specific genetic disorders. //

This has not only added motivation to scientists working in the field of genetics but also helped us replace the existing knowledge with those acquired new. One such breakthrough has been the successful attempts of transplanting human chromosome into animal models, more specifically, chromosome 21 into mice.

The presence of an extra copy of the 21st chromosome is responsible for Down syndrome, one of the most common autosomal chromosomal disorder. This move is anticipated to transform medical research into genetic causes of the disease.

Down's syndrome occurs in one in about every 800 live births and is also seen in a higher percentage of stillbirths and miscarriages. The chances of having a Down's syndrome baby increase as a woman ages. People with the disorder typically are of short stature and have undersized heads, downward-sloping eyes and mild to severe mental disabilities.

In addition to Down's syndrome, chromosome 21 is also linked to early-onset Alzheimer's disease, certain types of leukaemia, a form of manic depression and congenital heart disease.

With experiments such as this gathering momentum in the field of genetics, the successful treatment of genetic disorders seems a reachable goal in the future.
'"/>




Page: 1

Related medicine news :

1. Sweaty palms syndrome can be cured by surgery
2. Treatment for pre-menstrual syndrome is ineffective
3. Artists prone to cubital tunnel syndrome
4. Shelved bowel-syndrome drug still in demand
5. Down syndrome life anticipation doubles
6. Restless leg syndrome can be a family trait
7. Restless leg syndrome may remain under-diagnosed in many
8. Calcium and Vitamin D reduces risk of Premenstrual syndrome
9. Warding off symptoms of premenstrual syndrome by combination therapy
10. Roots of polycystic ovarian syndrome traced to mother’s wom
11. Substance abuse linked to adult antisocial syndrome
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... ... the continuation of its strategic partnership with and platinum sponsorship of Global Spine ... the safe and effective management of complex spine deformity cases, particularly in children. ...
(Date:4/24/2017)... FLORIDA (PRWEB) , ... April 24, 2017 , ... ... telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, ... LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project ... 2017: Telehealth 2.0 — the American Telemedicine Association’s annual conference, on April 23 in ... for using telemedicine to improve the lives of the poor and underserved in other ...
(Date:4/24/2017)... TX (PRWEB) , ... April 24, 2017 , ... As ... Memorial Museum today to honor the victims of the Holocaust and Nazi persecution, ... ceremonies at Hadamar and Auschwitz on its CMATH Champions trip to Germany and Poland ...
(Date:4/24/2017)... TX (PRWEB) , ... April 24, 2017 , ... The ... the glitterati, those unreal icons inhabiting the rarified air of pop and film stardom.(1) ... paparazzi and anyone snapping pictures: the smile. Grins now run the gamut from being ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities ... to their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming ... provides an in-depth assessment of the current trends in ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
Breaking Medicine Technology: